Delivery Order SPE2DR25D2005-SPE2DR26FE6G2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,065.75 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, ultimately completed on August 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order was issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,193.47 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,343.04 on September 17, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by September 18, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $16,224.45 to AmerisourceBergen Drug Corp for 180 tablets of Janumet XR 50-1,000 mg on September 16, 2025, with a completion date of September 17, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $32,272.39 to AmerisourceBergen Drug Corp for 180-count supplies of Janumet XR 50-1,000 mg tablets, a combination diabetes medication. This is a firm fixed-price, non-set-aside contract with a completion date of September 15, 2025, executed on September 12, 2025. The order is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This competitively awarded, non-set-aside contract involves firm fixed pricing and is scheduled for completion by September 2, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $8,599.50. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at approximately $1 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.32 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60 count) on August 26, 2025, with a completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and represents a routine pharmaceutical procurement to support federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,909.49 to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order represents a...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6G2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,169.04 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets (60-count units). The contract was competitively awarded without set-aside designation under a firm fixed-price structure, with an ultimate completion date of November 6, 2025. AmerisourceBergen's Conshohocken, Pennsylvania corporate office will serve as the place of performance for this order. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains significant capacity to fulfill federal medical procurement requirements across multiple therapeutic domains, with this particular order addressing diabetes management needs within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 11/5/25 |